Brookline Capital Markets Downgrades MEI Pharma (MEIP) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Brookline Capital Markets Downgrades MEI Pharma (MEIP) to Hold

MEI Pharma (MEIP) to Consider Strategic Alternatives

July 22, 2024 8:32 AM EDT

MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today announced that its Board of Directors has determined unanimously to begin evaluation of the Companys strategic alternatives, including potential transactions as well as an orderly wind down of the Company, if appropriate, in order to maximize the value of its assets for its stockholders. The Company intends to evaluate and engage a financial advisor to assist in this process.

In order to best preserve the Companys existing cash, the Company will commence a reduction-in-force beginning as soon as practicable and continuing in stages... More